An in-depth explanation of the side effects of beclomethasone/formoterol/glycopyrrolate spray (Trimbow)

Beclomethasone/formoterol/glycopyrrolate spray (Trimbow), as an innovation in the medical field, occupies an important position in the treatment of adults with moderate to severe chronic obstructive pulmonary disease (COPD) and asthma with its unique triple therapy mechanism. The drug cleverly combines the advantages of long-acting beta-2 receptor agonists, inhaled corticosteroids and long-acting muscarinic receptor antagonists to provide patients with a more comprehensive and efficient disease management strategy.

For COPD patients, specifically those whose disease cannot be effectively controlled even after combined treatment with two drugs, Trimbow has demonstrated significant therapeutic effects. It effectively improves patients' respiratory function by dilating the airways and reducing the inflammatory response in the airways and lungs, thereby improving their quality of life. For asthma patients, Trimbow also provides an effective treatment option for those adult patients whose condition repeatedly worsens after treatment with long-acting beta-2 receptor agonists combined with medium- to high-dose inhaled corticosteroids.

However, any drug may be accompanied by certain side effects while exerting a therapeutic effect. Trimbow is no exception. According to clinical research data, its side effects may affect as many as 1 in 10 users. Among them, dysphonia or voice changes are one of the more common side effects, which may be related to the subtle effects of the drug on the throat muscles. In addition, oral candidiasis is also a problem that cannot be ignored. This oral fungal infection caused by Candida may cause patients to experience oral pain, ulcers and other uncomfortable symptoms, affecting daily life. In addition to the above side effects, Trimbow may also cause muscle cramps and dry mouth. Muscle spasms may be related to the regulatory effect of drugs on the neuromuscular system, while dry mouth may be due to the drugs inhibiting the secretion function of salivary glands to a certain extent. It is worth noting that in patients with asthma, these side effects tend to be more common in the first three months of treatment and may gradually lessen as the body adapts.

It is important for patients who are usingTrimbow to understand and pay close attention to these potential side effects. During the medication process, patients should maintain a high degree of self-observation awareness. Once any symptoms of discomfort occur, they should seek medical treatment immediately and describe the situation to the doctor in detail. At the same time, patients should strictly follow the doctor's instructions, use drugs correctly and standardly, and undergo regular review so that the doctor can promptly evaluate the treatment effect and adjust the treatment plan.

In summary, beclomethasone/Formoterol/glycopyrrolate spray (Trimbow), as a highly effective triple therapy drug, brings treatment hope to patients with COPD and asthma, but it may also be accompanied by some side effects. Therefore, patients should fully understand these potential risks when using them and pay close attention to their body's reactions to ensure the safety and effectiveness of the medication.

Reference: https://www.ema.europa.eu/en/medicines/human/EPAR/trimbow